Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 3.5

The market opened in green on August 12, 2021, overall volumes in futures & options currently stand at 7,39,02,113 contracts with a turnover of Rs. 63,81,494.92 crore.

Stock SIP in these multibagger stocks would have outperformed the best of MFs; have a look!
Stock SIP in these multibagger stocks would have outperformed the best of MFs; have a look!

Stock SIP in these multibagger stocks would have outperformed the best of MFs; have a look!

Yogesh Supekar Article rating: 3.3

Some of the top performing mutual fund have been able to deliver close to 30 per cent annualized returns in the past 5 years. It is worth noting here that ICICI Prudential Technology Fund has delivered ~30 per cent annualised returns in the past 5 years. 

High momentum stocks for todays trade: Price and volume busters!
High momentum stocks for todays trade: Price and volume busters!

High momentum stocks for todays trade: Price and volume busters!

Karan Dsij Article rating: 3.5

It’s important to note that we are still in the initial part of the trading session and there are as many as 22 stocks on NSE Exchange, which meets this criterion.  Keep a watch on these stocks. 

MF Risk Measures: When Less Is More
MF Risk Measures: When Less Is More

MF Risk Measures: When Less Is More

The next time that you select a fund, remember that less risk not only means less pain but more gain also. The article explains the how and why of this theory

Ninad Ramdasi Article rating: 4.8

The next time that you select a fund, remember that less risk not only means less pain but more gain also. The article explains the how and why of this theory

Cipla receives final approval for its abbreviated new drug application
Cipla receives final approval for its abbreviated new drug application

Cipla receives final approval for its abbreviated new drug application

Cipla’s Difluprednate Ophthalmic Emulsion 0.05 per cent is an AB-rated generic therapeutic equivalent version of Novartis Pharmaceutical Corporation’s Durezol®. 

Armaan Madhani Article rating: 3.6

Pharmaceutical major Cipla has received final approval for generic version of Novartis Pharmaceuticals Corporation Durezol® (Difluprednate Ophthalmic Emulsion 0.05 per cent) from United States Food & Drug Administration (US FDA). 

Stove Kraft zooms 5 per cent; installs Indias first solar PV rooftop system
Stove Kraft zooms 5 per cent; installs Indias first solar PV rooftop system

Stove Kraft zooms 5 per cent; installs Indias first solar PV rooftop system

Stove Kraft estimates that this project will reduce its carbon footprint by 5,000 MT and also, help in reducing its dependency on non-renewable energy.

Armaan Madhani Article rating: 4.0

On August 10, 2021, Stove Kraft inaugurated India’s first solar PV rooftop system with higher efficiency mono PERC 535/540Wp PV module. The company has implemented this project in its Bengaluru factory, which has more than 4,50,000 sq. ft roof space and is spread across 16 acres. This is a giant step towards reducing carbon emissions and producing clean energy. 

RSS
First21082109211021112113211521162117Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR